Hanson v. Theranest, LLC

District Court, S.D. California·Decided September 25, 2024·No. 3:24-cv-00086·Unknown

Opinion

1 2 3 4 5 6 7 8 9 UNITED STATES DISTRICT COURT 10 SOUTHERN DISTRICT OF CALIFORNIA 11 12 LAURA HANSON, Case No.: 24-cv-00086-AGS-JLB 13 Plaintiff, ORDER GRANTING IN PART AND DENYING IN PART DEFENDANTS’ 14 v. MOTION FOR PROTECTIVE 15 THERANEST, LLC, et al., ORDER

16 Defendants. [ECF No. 42] 17

18 Before the Court is a Motion for Protective Order filed by Defendants TheraNest, 19 LLC (“TheraNest”), Therapy Brands Holdings, LLC (“Therapy Brands”), and Jennifer 20 Wolfe (collectively “Defendants”) (ECF No. 42), which Plaintiff Laura Hanson 21 (“Plaintiff”) opposes (ECF No. 43). On September 19, 2024, Defendants filed a reply 22 (ECF No. 48), and on September 23, 2024, Plaintiff filed a surreply (ECF No. 49). For the 23 reasons set forth below, Defendants’ motion is GRANTED in part and DENIED in part. 24 I. BACKGROUND 25 A. Underlying Case 26 The instant case arises out of Plaintiff’s employment as a Director of Compliance by 27 and subsequent termination from TheraNest. (See generally ECF No. 24, Second Amended 28 Complaint (“SAC”).) Plaintiff alleges she suffered serious, disabling injuries from a motor 1 vehicle accident on March 1, 2020, that necessitated her taking intermittent leave under the 2 Family Medical Leave Act and California Family Rights Act between March 2020 and 3 February 2021. (SAC ¶ 17.) Plaintiff’s SAC raises claims of discrimination, hostile work 4 environment, harassment, and retaliation based on Plaintiff’s disability, along with failure 5 to prevent discrimination and harassment, failure to engage in the interactive process, and 6 failure to accommodate her disability. (See generally SAC.) 7 B. Instant Discovery Dispute 8 On May 17, 2024, Plaintiff served an initial 30(b)(6) deposition notice on Therapy 9 Brands that listed 25 topics, and then served an amended 30(b)(6) deposition notice 10 (“Amended Notice”) listing 28 topics on June 3, 2024. (ECF Nos. 42-1 at 2.) After 11 Therapy Brands served objections to the Amended Notice, the parties met and conferred 12 to narrow the disputed issues from all 28 topics to 14 topics. (ECF Nos. 42-1 at 2.) On 13 July 12, 2024, the parties lodged a Joint Discovery Statement, and the Court set a Discovery 14 Conference for July 19, 2024. (ECF Nos. 42-1 at 2; 30.) On July 18, 2024, Plaintiff served 15 a second amended 30(b)(6) deposition notice (“Second Amended Notice”) listing 46 topics 16 (ECF Nos. 42-1 at 2–3; 42-6), so the Court reset the July 19, 2024 Discovery Conference 17 for August 2, 2024, to provide counsel time to meet and confer regarding the Second 18 Amended Notice (ECF No. 32). The Court held Discovery Conferences on August 2, 19 August 23, and August 30, 2024, after which the Court issued a briefing schedule for the 20 instant motion. (ECF Nos. 33; 37; 40.) 21 II. LEGAL STANDARD 22 A party is entitled to seek discovery of “any nonprivileged matter that is relevant to 23 any party’s claim or defense and proportional to the needs of the case, considering the 24 importance of the issues at stake in the action, the amount in controversy, the parties’ 25 relative access to relevant information, the parties’ resources, the importance of the 26 discovery in resolving the issues, and whether the burden or expense of the proposed 27 discovery outweighs its likely benefit.” Fed. R. Civ. P. 26(b)(1). Information need not be 28 admissible to be discoverable. Id. Rule 30 further provides that a party may notice the 1 deposition of “a public or private corporation, a partnership, an association, a governmental 2 agency, or other entity.” Fed. R. Civ. P. 30(b)(6). Such notice “must describe with 3 reasonable particularity the matters for examination.” Id. 4 Although “[d]istrict courts have broad discretion in determining relevancy for 5 discovery purposes,” Surfvivor Media, Inc. v. Survivor Prods., 406 F.3d 625, 635 (9th Cir. 6 2005) (citation omitted), discovery of relevant information is not limitless. The Court 7 must—either on motion or sua sponte—“limit the frequency or extent” of otherwise 8 permissible discovery if the Court finds the request “unreasonably cumulative or 9 duplicative” or the discovery sought is obtainable from a “more convenient, less 10 burdensome, or less expensive” source. Fed. R. Civ. P. 26(b)(2)(C)(i). 11 Rule 26(c) further provides that, “[t]he court may, for good cause, issue an order to 12 protect a party or person from annoyance, embarrassment, oppression, or undue burden or 13 expense[.]” Fed. R. Civ. P. 26(c)(1). “The burden is on the person seeking the protective 14 order to demonstrate good cause.” Grano v. Sodexo Mgt., Inc., 335 F.R.D. 411, 414 (S.D. 15 Cal. 2020) (citing U.S. v. $160,066.98 from Bank of America, 202 F.R.D. 624, 626 (S.D. 16 Cal. 2001). “The court has wide discretion to determine what constitutes a showing of 17 good cause and to fashion a protective order that provides the appropriate degree of 18 protection.” Id. (citing Seattle Times Co. v. Rhinehart, 467 U.S. 20, 36 (1984)); see also 19 Alvarado-Herrera v. Acuity, 344 F.R.D. 103, 107, n.3 (D. Nev. 2023), aff’d sub nom. 20 Alvarado-Herrera v. Acuity A Mut. Ins. Co., No. 222CV00438CDSNJK, 2023 WL 21 5035323 (D. Nev. Aug. 4, 2023) (“While [Rule] 26(b)(1) permits a party to obtain 22 discovery regarding any nonprivileged matter that is relevant to any party’s claim or 23 defense, courts have limited discovery where the breadth of subjects and number of topics 24 identified in a [Rule] 30(b)(6) deposition notice renders a responding party’s efforts to 25 designate a knowledgeable person unworkable.”); U.S. v. HVI Cat Canyon, Inc., No. CV 26 11-5097 FMO (SSX), 2016 WL 11683593, at *7 (C.D. Cal. Oct. 26, 2016) (“While a 27 corporation must make a good faith effort to prepare a 30(b)(6) witness to fully and 28 unevasively answer questions about the designated subject matter that task becomes less 1 realistic and increasingly impossible as the number and breadth of noticed subject areas 2 expand.”) (internal punctuation and citation omitted). 3 III. DISCUSSION 4 At issue are topic numbers 4, 14, 16, 17, 21–23, 25–27, 33–36, and 39–46.1 5 Defendants generally argue that the disputed topics are overbroad and lack necessary 6 specificity.2 (See generally ECF No. 42-1.) Defendants’ motion itself does not dive into 7 particular detail about every disputed topic, instead relying on general conclusions that 8 certain topics are “objectionable,” “overbroad,” “vague,” and “not specific.”3 (See, e.g., 9 10 11 1 Although Defendants’ motion includes topic number 15, Plaintiff’s opposition states that it was withdrawn and “turned into an interrogatory per the demand of Defendants. . . .” 12 (ECF No. 43 at 5, n.1.) Accordingly, based on Plaintiff’s representation, the Court does 13 not address topic number 15. 2 The objections Defendants served in response to Plaintiff’s Second Amended Notice 14 were largely identical and improperly boilerplate, listing objections based on the definition 15 of terms, lack of specificity, relevance, proportionality, attorney-client privilege, attorney work product doctrine, overbreadth, vagueness, and ambiguity. (See generally ECF No. 16 42-4.) “Boilerplate, generalized objections are inadequate and tantamount to not making 17 any objection at all.” Walker v. Lakewood Condo. Owners Ass’n, 186 F.R.D. 584, 587 (C.D. Cal. 1999).

Free access — add to your briefcase to read the full text and ask questions with AI

Hanson v. Theranest, LLC, (S.D. Cal. 2024).

Hanson v. Theranest, LLC (Hanson v. Theranest, LLC) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related